Healthcare -
Biotechnology - NASDAQ - US
$ 1.8267
-4.86 %
$ 19.6 M
Market Cap
-1.71
P/E
MRKR - REVENUE
Revenue MRKR - Marker Therapeutics, Inc.
3.31 M
LAST VALUE
63.30%
2 YEAR CAGR
74.27%
5 YEAR CAGR
0.00%
10 YEAR CAGR